About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term...
Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to...
A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.
An investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in...
In the diagnosis of skin conditions caused by parasitic mites, a recent research study has outlined distinct advantages in the use of confocal microscope over the usual light microscope.
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary...
There has been public concern about the safety of nanoparticle sunscreens, but the available evidence indicates that they are both effective and safe to use, according to a Perspective published in...
Potential exists to make more patients responsive to advanced treatments.Patients who don't respond to treatments that use their own immune cells to destroy tumors, called tumor infiltrating...